PBL 5 Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

what is a cholinesterase inhibitor

A

stops acetylcholinesterase enzyme from breaking down acetylcholine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

define dementia

A

it is a chronic progressive neurodegenerative condition that results in impairments in cognition to impair acitivies of daily living

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

name types of dementia

A

alzheimers
vascular dementia
frontal temporal
dementia with lewy bodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what 3 things is there a progressive decline of in dementia

A

o Memory and Reasoning
o Communication Skills
o Inability to carry out daily activities.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what other conditions does dementia need to be distinguished from

A

o Normal Ageing: mild, benign memory loss.

o Delirium: acute and reversible disturbance of higher mental function, usually associated with
impaired conscious level and caused by infection, toxic, metabolic substances.

o Pseudodementia: cognitive effect of severe depressive illness.
 Difficult to separate from dementia as depression is often secondary to dementia.

o Apathy: loss of motivation that lacks the emotional content of a depressive illness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are early clinical features of dementia

A

 Short-term memory loss.
 Disorientation in time.
 Reduced judgement and planning ability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the modifiable risk factors and the non modifiable risk factors of dementia

A

non modifiable

  • age
  • genetic
  • family history
  • Down syndrome

modifiable

  • vascular
  • cognitive inactivity
  • environment
  • depression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what 2 pathological things characterise dementia

A

 Senile/Neuritic Plaques (extracellular deposits of beta-amyloid peptide) particularly in the parietal
lobe/hippocampus.

 Intracellular Neurofibrillary Tangles: hyperpolarized tau protein.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are other structural hallmarks to dementia

A

 Synaptic and neural degeneration
 Severe atrophy of cerebral cortex (widening of the sulci).
 Enlargement of the ventricular system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what part of the brain is at risk of degeneration

A
  • medial temporal lobe including the hippocapal complex and entorhinal cortex
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what part of the brain is well preserved in the brain

A

Well preserved areas of the brain: primary sensory/motor

areas, upper regions of prefrontal cortex.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what 3 genes are responsible for early onset dementia

A

APP chromsome 21
presilin 1 chromsome 14
presilin 2 chromosome 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is APP function

A

 Involved in helping neuron growth and repair.

o Over time APP is broken down and recycled.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

where is APP expressed

A

Transmembrane protein expressed in neurons, glial cells, endothelial smooth muscle.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the two ways in which APP is recycled

A

non-amyloidogenic pathway

amyloidgenic pathway - pathological

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

describe the non amyloidgenic pathway

A

In normal non-amyloidogenic pathway, alpha and gamma
secretases do not form amyloid-beta peptides but cleave
up the protein into soluble form which is recycled.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

describe the amyloidgenic pathway

A

 In diseased amyloidogenic pathway, the transmembrane protein is wrongly cleaved by beta
and gamma secretases which leads to formation of non-soluble amyloid-beta peptides.
 These peptides aggregate to form senile plaques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what subunits is gamma secreted made out of

A

(!) The γ-secretase is made up of subunits. Of
note are PSEN1 and PSEN2 because mutations in
these can cause Alzheimer’s (PSEN1 being the
most common).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what do the plaques do to the nervous system

A

Can potentially get in-between the neurons which disrupts signalling.

 Therefore, impairs various
functions like memory.
o Start an immune response which causes
activation of microglia.
o Can also cause amyloid angiopathy
when around cerebral vessels

 Weakens walls and increases
risk of haemorrhage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is the normal function of TAU

A

 Neurons are held together by their cytoskeleton made up of microtubules.
o Ship nutrients and molecules along the cell.
o Located within the neuron.

 Tau stabilises microtubules through coordinated binding through kinases/phosphates.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What encodes for Tau

A

MAPT

22
Q

what does a mutation in MAPT cause

A

frontal temporal dementia

23
Q

what causes Tau to become hyperphosphorylated

A
 Oxidative stress from amyloid plaques cause
disregulation of kinase activity
o Kinase binds phosphate to the tau
protein and causes it to become
tangled (hyperphosphorylation) =
neurofibrillary tangles.

 Tangles stop microtubules form signalling
and can cause apoptosis.

24
Q

when is early onset dementia

A
  • between the ages of 30-60

- represents less than <5% of patients

25
Q

what is defined as late onset dementia

A

over age of 60

26
Q

what can cause late onset dementia

A

Strong genetic risk factor is apolipoprotein E (especially ApoE4) on chromosome 19.

Has three alleles
o ApoE2: relatively rare.
o ApoE3: most common and is believed to have a neutral role
o ApoE4: in about 40% of all late onset Alzheimer’s.

27
Q

what two dementias can you have at the same time

A

Mixed Dementia: vascular dementia and dementia Lewy bodies.

28
Q

what are the risk factors for vascular dementia

A

Risk factors are like those of Alzheimer’s (include diabetes, smoking, hypertension,
hypercholesterolaemia).

29
Q

describe vascular dementia

A

 Occurs in <20% of dementia cases.
 Series of infarcts secondary to cerebrovascular disease lead to neuronal loss.
o CT or MRI shows multiple infarcts.
o Diagnosis relies upon clinical impression/cognitive examining.
 Depending on the location of infracts, there is a pattern of cognitive impairments.
 Frequently arises out of subcortical ischaemic disease and then presents more insidiously.

30
Q

what is frontal temporal dementia /picks disease characterised by

A

Characterised by argyrophilic inclusion bodies (accumulate in frontal/temporal lobes).

31
Q

describe frontatemporal /picks disease

A

 Occurs in <20% of dementia cases.

 Used to describe several different conditions including:
o Frontotemporal dementia-behavioural variant: frontal lobe distribution of disease initially.
o Frontotemporal dementia-language variant: includes primary progressive aphasia/semantic
dementia, temporal distribution initially.

32
Q

describe dementia with levy bodies

A

 Characterized by:
o Marked fluctuation in symptoms.
o Vivid visual hallucinations.
o Extrapyramidal (parkinsonian) symptoms.

 Dementia symptoms will arise first before Parkinsonian symptoms.

 Supporting features:
o Greater number of impairments in attention and visuospatial orientation
o Postural instability with frequent falls.
o Positive DaTScan.

33
Q

what is dementia with Lewy bodies characterised by

A

o Marked fluctuation in symptoms.
o Vivid visual hallucinations.
o Extrapyramidal (parkinsonian) symptoms.

34
Q

dementia may also be a result of…

A

cerebral trauma

35
Q

what conditions can dementia occur in

A
  • cerebral tumours
  • parkinsons disease
  • Huntington’s disease
  • motor neurone disease
  • multiple sclerosis
36
Q

how do you diagnose dementia

A

 History Taking.
 Cognitive and Mental State Examination.
o Examination of attention, concentration, orientation, short and long-term memory etc…
 Physical Examination.
 Review of medication.

37
Q

what scans are done to rule out other causes of memory loss

A

 CT scan: rules out hydrocephalus/tumour
o Confirms cerebral trophy/vascular lesions.

 MRI: shows cerebral infarcts more clearly.

 HMPAO-SPECT: shows frontotemporal dementia.

38
Q

how does the mini mental examination work

A

Minimal Mental State Examination (MMSE): no longer free to use but works as follows (note: these
scores must be interpreted considering activities of daily living (AD).

o Maximum score is 30 points
o 20-24 suggest mild dementia.
o 13-20 suggest moderate dementia.
o Less than 12 suggest severe dementia.

  • in alzhiemers disease the score decreases by 2-4 each year
39
Q

what is the Montreal cognitive assessment score out of

A

30

40
Q

why is the Montreal congtivie assessment better than the mini mental state examination

A

Better than MMSE because of it tests a greater variety of cognitive domains, is free and
discriminations more accurately between ageing and mild cognitive impairment.

41
Q

describe basic dementia screening tests that should be done

A

 Routine haematology.
 Biochemistry tests (electrolytes, calcium, glucose, renal/liver function).
 Thyroid function tests.
 Serum vitamin B12/folate levels.

42
Q

describe how learning and memory happens and what effect dementia has on this

A

Learning and memory are associated with changes in various brain regions:
o Corticolimbic circuits

o Long-term potentiation/depression (LTP/LTD): changes in synaptic connections/efficiency.
 Potentiation = increase in synaptic strength
 Depression = decrease in synaptic strength.

o Reduced Excitatory Synaptic Transmission: due to elevated alpha beta amyloid peptides.
 Reduce the AMPA (AMPARs) and NMDA glutamate receptors (NMDARs).
 Shift activation of these pathways to pathways involved in induction of LTD/synaptic
loss (impairs LTP and enhances LTD).

43
Q

name some acetylcholinesterase inhibitors ( used in mild to moderate)

A

 Donepezil
 Galantamine
 Rivastigmine

44
Q

what is the mechanism of action of acetylcholinervse inhibitors

A

 Cholinergic forebrain pathways innervating limbic/cortical structures degenerate in AD. Especially:

 Basal forebrain cholinergic system.
 Nucleus Basalis of Meynert.
 Horizontal/vertical diagonal bands of Broca.
 Medial Septal Nucleus.

o Inhibiting acetylcholinesterase stops breakdown of acetylcholine.
o Acetylcholine which promotes healthy cognition (alertness, level of interest etc…).
 These drugs are also effective in DwLB.

45
Q

what are the moderate/severe stages drugs used for dementia

A

NMDA receptor antagonists

46
Q

name NMDA receptor antagonists

A

Memantine

47
Q

what is the mechanism of action of NDMA receptor antagonists

A

 AD may be associated with a slow form of excitoxicity and increased glutamate.
o Blocking release of glutamate help easing distressing/challenging behaviours/delusion.

48
Q

what non pharmacological therapies should be used for alzheiemrs

A

Cognititive Stimulation Theraphy
 Should be offered to all newly diagnosed patients.
 Delivered in a seven-week course.
 Learning about impairments and how to manage them.

Reminiscence Theraphy
 Discussion of past activities, events and experiences.

49
Q

describe the prognosis of the patient

A

 John is expected to decline over several years.
o Average duration is 8-10 years but this varies largely between individuals.
 He will become completely dependent and may require medium/long-term nursing care.

50
Q

describe help places for patients with dementia

A

Admiral Nurses
 Mental Health nurses specialised in dementia.
o Provide tools/skills to help family with condition.
o Invaluable source of contact/support for families.

Alzheimer’s Society Dementia Advisors:
 Non-clinical professionals who assist in similar ways to the admiral nurses.

Advance Care Planning
 Allows him to make choices and decisions about his future care.